↓ Skip to main content

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Overview of attention for article published in BMC Cancer, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
9 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
144 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
Published in
BMC Cancer, January 2013
DOI 10.1186/1471-2407-13-10
Pubmed ID
Authors

Rémi Marty, Stéphane Roze, Xavier Bresse, Nathalie Largeron, Jayne Smith-Palmer

Abstract

HPV is related to a number of cancer types, causing a considerable burden in both genders in Europe. Female vaccination programs can substantially reduce the incidence of HPV-related diseases in women and, to some extent, men through herd immunity. The objective was to estimate the incremental benefit of vaccinating boys and girls using the quadrivalent HPV vaccine in Europe versus girls-only vaccination. Incremental benefits in terms of reduction in the incidence of HPV 6, 11, 16 and 18-related diseases (including cervical, vaginal, vulvar, anal, penile, and head and neck carcinomas and genital warts) were assessed.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Netherlands 1 <1%
Denmark 1 <1%
Guatemala 1 <1%
Unknown 140 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 30%
Student > Bachelor 23 16%
Student > Ph. D. Student 14 10%
Researcher 11 8%
Student > Doctoral Student 10 7%
Other 25 17%
Unknown 18 13%
Readers by discipline Count As %
Medicine and Dentistry 61 42%
Agricultural and Biological Sciences 12 8%
Nursing and Health Professions 10 7%
Social Sciences 9 6%
Immunology and Microbiology 5 3%
Other 21 15%
Unknown 26 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2014.
All research outputs
#858,747
of 5,036,908 outputs
Outputs from BMC Cancer
#237
of 2,818 outputs
Outputs of similar age
#53,990
of 287,958 outputs
Outputs of similar age from BMC Cancer
#11
of 103 outputs
Altmetric has tracked 5,036,908 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,818 research outputs from this source. They receive a mean Attention Score of 2.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,958 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.